Not applicable
The results from preclinical studies conducted with Airtal are consistent with those expected for NSAIDs. The principal target organ was the gastro-intestinal tract.
No unexpected findings were recorded.
Airtal was not considered to have any mutagenic activity in three in vitro studies and an in vivo study in the mouse.
Airtal was not found to be carcinogenic in either the mouse or rat.
Any unused product or waste material should be disposed of in accordance with local requirements.
